SecBot SecBot
SECBOTREPLAY Home › Report › VTVT

VTVT · vTv Therapeutics filed a DEFA14A to correct an inadvertent omission…

vTv Therapeutics Inc. · DEFA14A filed Jun 10, 2026 at 16:10 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Jun 10, 2026 at 16:10 ET

vTv Therapeutics filed a DEFA14A to correct an inadvertent omission from its 2026 proxy statement, adding an advisory vote (Say-on-Pay) on executive compensation as Proposal 3. The annual meeting was adjourned from June 10 to June 26, 2026, without transacting any business, to allow shareholders time to review the new proposal. This is a routine administrative correction with no material financial or strategic impact.

  • Original proxy statement (filed April 28, 2026) inadvertently omitted Proposal 3 for an advisory vote on executive compensation.
  • Annual meeting convened June 10, 2026 was adjourned immediately without any business transacted.
  • Adjourned meeting will resume June 26, 2026 at 11:00 AM ET via virtual webcast.
  • Record date remains April 14, 2026; voting deadline extended to June 24, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access